Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease

Completed · Phase 4

Conditions studied: Sleep Disturbance, Fatigue, Inflammatory Bowel Disease

In brief

The purpose of this study is to determine if either a targeted type of talk therapy (Phase I) or medication, Wellbutrin, (Phase II) improve sleep disturbance and/or fatigue in individuals with Inflammatory Bowel Disease (IBD).

Key facts

Study ID
NCT02162862
Run by
Eva Szigethy
People needed
99
Starts
2013-07-01
Expected to finish
2016-06-30
Last updated by the study team
2017-09-13

Who can join

Age: 15 and older, up to 30. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.